Thoratec reports positive trial results for heart pump

12/5/2008 | Reuters

Thoratec Corp. said an interim analysis of a Phase III trial of its HeartMate II showed that the device is statistically better than its other cardiac pump in treating patients who are ineligible for a transplant. The company plans to seek premarket approval from the FDA in the first half of next year to sell HeartMate II as a destination treatment.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC